Related Experiment Video
Updated: Jun 23, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
The New Tumor Predisposition Syndromes with Neuro-Oncological Relevance-A Comprehensive Review for Neuroradiologists
Reinhold Nafe1, Luciana Porto2, Anke Barnbrock3
1Department of Neuroradiology, Goethe University Frankfurt/Main, University Hospital Frankfurt DE, Germany. Reinhold.Nafe@unimedizin-ffm.de.
The 5th edition of the WHO CNS tumor classification includes new tumor predisposition syndromes (TPS). Familiarity with these novel TPS is crucial for neuroradiologists to guide genetic testing and diagnosis.
Area of Science:
- Neuro-oncology
- Genetics
- Radiology
Background:
- The 5th edition of the WHO Classification of Tumors of the Central Nervous System (CNS) introduced new tumor predisposition syndromes (TPS).
- Neuroradiologists need to recognize these novel TPS for accurate diagnosis and genetic testing.
- Imaging findings in TPS-associated tumors are often similar to sporadic forms, necessitating a comprehensive approach.
Purpose of the Study:
- To review the novel tumor predisposition syndromes (TPS) introduced in the 5th edition of the WHO Classification of Tumors of the CNS.
- To discuss the phenotypic spectrum and genetic aspects of these TPS for neuroradiologists.
- To highlight the importance of genetic knowledge in diagnosing and understanding the heterogeneity of TPS.
Main Methods:
- Review of the 5th edition of the WHO Classification of Tumors of the CNS.
- Discussion of current knowledge on the phenotypic spectrum of new TPS.
- Analysis of the role of genetic mutations in TPS manifestation.
Main Results:
- The 5th edition of the WHO CNS tumor classification incorporates new TPS entities.
- Neuroradiological features alone are often insufficient for definitive TPS diagnosis.
- Genetic knowledge is essential for understanding the diversity and complexity of TPS, aiding in diagnosis and clinical management.
Conclusions:
- Neuroradiologists must be aware of the new TPS entities and their associated imaging patterns.
- Genetic information is critical for confirming TPS diagnoses and appreciating syndrome heterogeneity.
- This review provides valuable insights into newly classified and relevant TPS for neuro-oncology practice.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
